Variations in the mineral content of bottled 'carbonated or sparkling' water across Europe: a comparison of 126 brands across 10 countries.

kidney stone disease mineral composition mineral content sparkling water urolithiasis

Journal

Central European journal of urology
ISSN: 2080-4806
Titre abrégé: Cent European J Urol
Pays: Poland
ID NLM: 101587101

Informations de publication

Date de publication:
2021
Historique:
received: 16 11 2020
revised: 25 01 2021
accepted: 25 01 2021
entrez: 12 5 2021
pubmed: 13 5 2021
medline: 13 5 2021
Statut: ppublish

Résumé

Kidney stone disease is a common disease with high recurrence rates. Sufficient intake of water is the cornerstone in primary prevention of stone disease. However, the mineral composition of water can affect urinary minerals and influence stone formation. The aim of this study is to assess the variation in the mineral composition of bottled sparkling or carbonated drinking water across Europe. The two largest supermarket chains in each participating country were visited to obtain data on mineral composition regarding bicarbonate, calcium, magnesium, potassium, sodium and sulphates of sparkling or carbonated waters by reading the ingredient labels on the bottles supplied by the manufacturers. Alternatively, the web-shops of these supermarkets were consulted. In total, 126 sparkling water brands across ten European countries were analysed regarding mineral composition. The median concentrations per mineral varied greatly. The greatest variation in median mineral content was found for sodium and sulphates with levels ranging from 3.1 mg/l to 63.0 mg/l and 6.0 mg/l to 263.0 mg/l respectively. A wide distribution of calcium content was found in Switzerland, with calcium levels reaching up to 581.6 mg/l. This study confirms that the mineral composition of sparkling or carbonated water varies greatly across Europe. Patients with kidney stone disease should be aware that the mineral content of water may influence stone formation and be mindful of the great variation that exists between different water brands. Mineral water can be a source of potential promotors or inhibitors of stone formation and patients and urologists need to be mindful of this.

Identifiants

pubmed: 33976919
doi: 10.5173/ceju.2021.0331.R1
pii: 0331.R1
pmc: PMC8097654
doi:

Types de publication

Journal Article

Langues

eng

Pagination

71-75

Informations de copyright

Copyright by Polish Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Urol Int. 2017;98(4):391-396
pubmed: 27694759
Eur J Clin Nutr. 2004 Feb;58(2):270-6
pubmed: 14749747
BJU Int. 2020 Apr;125(4):586-594
pubmed: 31916369
Curr Urol Rep. 2016 Dec;17(12):88
pubmed: 27771854
Am J Clin Nutr. 2010 Mar;91(3):565-70
pubmed: 20042524
J Endourol. 2017 Aug;31(8):729-735
pubmed: 28338351
Ann Intern Med. 1989 Dec 15;111(12):1006-9
pubmed: 2688503
World J Urol. 2007 Jun;25(3):315-23
pubmed: 17333204
Nutr Rev. 2015 Sep;73 Suppl 2:141-7
pubmed: 26290299
Curr Urol Rep. 2020 Feb 3;21(1):6
pubmed: 32016596
J Endourol. 2021 Feb;35(2):206-214
pubmed: 32762257
Ann Intern Med. 1980 Jul;93(1):36-9
pubmed: 7396311
Actas Urol Esp. 2009 Jul-Aug;33(7):778-93
pubmed: 19757664
Turk J Urol. 2020 Nov;46(Supp. 1):S92-S103
pubmed: 32525478
J Endourol. 2016 Mar;30(3):246-53
pubmed: 26576717
Eur Urol. 2015 Apr;67(4):750-63
pubmed: 25454613
J Pediatr Urol. 2019 Oct;15(5):467.e1-467.e7
pubmed: 31235439

Auteurs

Simone J M Stoots (SJM)

University of Amsterdam, Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.

Rob Geraghty (R)

Freeman Hospital, Department of Urology, Newcastle, United Kingdom.

Guido M Kamphuis (GM)

University of Amsterdam, Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.

Enakshee Jamnadass (E)

University Hospital Southampton NHS Trust, Department of Urology, Southampton, United Kingdom.

Michaël M E L Henderickx (MMEL)

University of Amsterdam, Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.

Eugenio Ventimiglia (E)

IRCCS Ospedale, Urological Research Institute, Division of Experimental Oncology/Unit of Urology, San Raffaele, Milan, Italy.

Olivier Traxer (O)

Sorbonne University, GRC#20 Urolithiasis, Paris, France.

Etienne X Keller (EX)

University of Zurich, University Hospital Zurich, Department of Urology, Zurich, Switzerland.

Vincent De Coninck (V)

AZ Klina, Department of Urology, Brasschaat, Belgium.

Michele Talso (M)

ASST Fatebenefratelli-Sacco - Luigi Sacco University Hospital, Department of Urology, Milan, Italy.

Panagiotis Kallidonis (P)

University of Patras, Department of Urology, Patras, Greece.

Esteban Emiliani (E)

Fundació Puigvert, Autonomous University of Barcelona, Department of Urology, Barcelona, Spain.

Ewa Bres-Niewada (E)

Roefler Memorial Hospital, Department of Urology, Pruszków, Poland.

Sadaf S Karim (SS)

University Hospital Southampton NHS Trust, Department of Urology, Southampton, United Kingdom.

Angela Piccirilli (A)

Fundació Puigvert, Autonomous University of Barcelona, Department of Urology, Barcelona, Spain.

Athanasios Vagionis (A)

University of Patras, Department of Urology, Patras, Greece.

Bhaskar K Somani (BK)

University Hospital Southampton NHS Trust, Department of Urology, Southampton, United Kingdom.

Classifications MeSH